GLYCOBREEZ F DPI

Glycobreez F DPI is a formulation that combines two active ingredients to facilitate easier breathing for individuals suffering from chronic obstructive pulmonary disease (COPD). It functions by inhibiting the release of specific chemical signals that lead to inflammation, which serves to relax the airway muscles. It is crucial to follow your healthcare provider’s instructions regarding the frequency of inhaler use. Administering the minimum effective dose is essential for optimal asthma management. While the initial effects of this medication may become apparent within a few days, it typically takes several weeks for the full benefits to manifest. Consistent use of this medication is necessary to maintain its effectiveness, even in the absence of symptoms, as discontinuation may result in the worsening of asthma conditions. It is important to note that this medication is not intended to treat sudden asthma episodes; in such instances, utilize a fast-acting inhaler designed for quick relief. Common adverse reactions may include digestive discomfort, throat and nasal passage inflammation, chest discomfort, elevated body temperature, throat soreness, coughing, headaches, sinusitis, nasal inflammation, and urinary tract infections. If you experience any of these symptoms, do not cease taking the medication; however, consult your doctor for further guidance. To minimize potential side effects, consider rinsing your mouth and throat with water or brushing your teeth following inhaler use. Additionally, it’s advisable to avoid known asthma triggers and refrain from smoking.